Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Exp Hypertens. 2006 Apr-May;28(3-4):251-7.

Atrial fibrillation and stroke: from scientific evidence to practice.

Author information

  • 1Department of Pharmacology, Faculty of Medicine, Lille, France. d-deplanque@chru-lille.fr

Abstract

Nonvalvular atrial fibrillation (NVAF) is the most frequent cause of cardioembolic stroke. Due to the aging of the population, NVAF is becoming an important public health issue. Despite the impressive results of trials with oral anticoagulation (OAC) in primary and secondary prevention of stroke in NVAF patients, OAC remains underused or misused in practice. Beyond the risk of bleeding, there also are several arguments for a lack of knowledge about trials and guidelines. Medical education could then be one of the most effective way to improve stroke prevention in NVAF patients in practice.

PMID:
16833031
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk